Testosterone hexahydrobenzoate

Enzalutamide-d 6 is a deuterium labeled Enzalutamide (MDV3100). Enzalutamide is an androgen receptor (AR) antagonist with an IC50 of 36 nM in LNCaP prostate cells.Form:Solid.

Enzalutamide-d 6 is a deuterium labeled Enzalutamide (MDV3100). Enzalutamide is an androgen receptor (AR) antagonist with an IC50 of 36 nM in LNCaP prostate cells.Form:Solid.

Ethyl 5-bromo-2-hydroxybenzoate.

Ethyl 6-ethoxy-2-hydroxybenzoate.

Ethyl 6-ethoxy-2-hydroxybenzoate.

application：Organohalide based perovskites have emerged as an important class of material for solar cell applications. Our perovskites precursors are useful for synthesizing mixed cation or anion perovskites needed for the optimization of the band

application：Organohalide based perovskites have emerged as an important class of material for solar cell applications. Our perovskites precursors are useful for synthesizing mixed cation or anion perovskites needed for the optimization of the band

application：Organohalide based perovskites have emerged as an important class of material for solar cell applications. Our perovskites precursors are useful for synthesizing mixed cation or anion perovskites needed for the optimization of the band

EZM0414 TFA is a potent, selective and orally active inhibitor of SETD2 which is a human histone methyltransferase . EZM0414 TFA has anti-proliferative effectsForm:SolidIC50&amp: Target:SETD2.

InformationFG-2216 FG-2216 is a potent, and orally active HIF prolyl 4-hydroxylase inhibitor with IC50 of 3.9 μM for PHD2 . Phase 2.TargetsPHD2 (Cell-free assay) 3.9 μMIn vitroFG-2216 shows the ability to stabilize HIF-α to stimulate EPO

InformationFG-2216 FG-2216 is a potent, and orally active HIF prolyl 4-hydroxylase inhibitor with IC50 of 3.9 μM for PHD2 . Phase 2.TargetsPHD2 (Cell-free assay) 3.9 μMIn vitroFG-2216 shows the ability to stabilize HIF-α to stimulate EPO

InformationFG-2216 FG-2216 is a potent, and orally active HIF prolyl 4-hydroxylase inhibitor with IC50 of 3.9 μM for PHD2 . Phase 2.TargetsPHD2 (Cell-free assay) 3.9 μMIn vitroFG-2216 shows the ability to stabilize HIF-α to stimulate EPO